S&P 500

Biotech

Vaccine Stocks Rise Sharply as New Omicron Variant Has Big Pharma Licking Its Chops

Since the omicron variant, which originated in southern Africa, began popping up in various countries worldwide, the S&P 500 (SPX)…

Read More »
Biotech

After a Breakout Year in 2021, Here’s Why Regeneron Stock Has Even More Upside

Regeneron Pharmaceuticals’ (NYSE: REGN) monoclonal antibodies cocktail REGEN-COV (casirivimab and imdevimab), which received emergency use authorization from the FDA in…

Read More »
Stocks

Capitalist Countdown: Wealthy VC’s Top 10 Investing News Stories of the Week

Unlike the many other mundane weekly news recaps, the team at Wealthy VC has made it its mission to scour…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content